IRDM (IRDM)
Quantitative Summary
DeterministicStrong operational fundamentals (Piotroski 7/9) with Altman Z of 1.5. DCF fair value of $69 implies 96% upside from current prices based on model assumptions.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency exhibits a modest positive spread, with ROIC at 7.6% exceeding the WACC of 6.7%, though this thin margin suggests limited excess returns relative to cost of capital. The DuPont decomposition reveals that the robust 24.7% ROE is primarily driven by high financial leverage (Equity Multiplier of 5.47x) rather than operational efficiency or pricing power, as asset turnover remains low at 0.34x despite healthy net margins of 13.1%. While the Piotroski F-Score of 7/9 indicates strong fundamental stability and the Beneish M-Score of -3.06 signals a very low probability of earnings manipulation, the Altman Z-Score of 1.5 flags potential distress risks that warrant caution regarding solvency under stress scenarios.
Valuation metrics present a divergent picture between historical norms and intrinsic value models. The current P/E ratio of 41.0x sits slightly above its five-year average of 33.2x, implying the market is pricing in growth expectations not yet reflected in recent performance where revenue grew only 4.9% year-over-yoer. However, a DCF analysis suggests significant upside potential with a fair value estimate of $69 and an implied return of 96.5%, creating a notable discrepancy between current market price and calculated intrinsic worth. This divergence may stem from the model's assumption of negative ten-year free cash flow growth (-2.4%), which could be penalizing the valuation if operational leverage fails to materialize despite high gross margins of 71.5%.
Insider activity remains neutral over the past ninety days, offering no directional signal regarding management sentiment toward current equity levels. The combination of a fragile solvency metric alongside leveraged returns and elevated pricing relative to recent history creates an asymmetric risk profile where downside protection is limited by leverage while upside relies heavily on future cash flow acceleration rather than proven historical execution.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 5% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 6% | 6.7% | 8.7% |
|---|---|---|---|
| 2% | $65 | $53 | $32 |
| 3% | $88 | $69 | $39 |
| 4% | $135 | $97 | $49 |
Center = base case. Green = >10% upside, Red = >10% downside vs $49.60.
Pre-computed DCF: WACC=6.7%, terminal growth 3%. Fair value $69 (+96.5%). Not investment advice.
Price Chart with Moving Averages
Technical Setup
AI GeneratedThe current trading price of $48.84 for IRDM establishes a specific point within its recent volatility range, offering a snapshot of where the asset stands relative to its moving average envelope. Without additional data points defining the upper and lower bands or the precise location of short-term simple moving averages, it is impossible to mathematically confirm whether this price represents an extension above the mean or a contraction below it. Consequently, any assessment regarding mean-reversion potential remains speculative at this stage, as the critical context required to determine if the stock is overextended or undervalued relative to its trend is absent from the provided figures. In isolation, the single data point of $48.84 does not reveal the dynamic relationship between price action and statistical norms necessary to gauge momentum shifts. Technical analysis relying on mean reversion typically requires observing how far a current level deviates from established averages over time; lacking this comparative framework, one cannot definitively state whether the market is poised for a correction toward a central tendency or if further deviation is likely. Observers must await a more complete dataset that includes moving average values and envelope boundaries to accurately interpret the structural positioning of IRDM within its recent price history.
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Dividend History
| Date | Amount | Change |
|---|---|---|
| 2026-03-16 | $0.1500 | 0.0% |
| 2025-12-15 | $0.1500 | 0.0% |
| 2025-09-15 | $0.1500 | +7.1% |
| 2025-06-13 | $0.1400 | 0.0% |
| 2025-03-17 | $0.1400 | 0.0% |
| 2024-12-16 | $0.1400 | 0.0% |
| 2024-09-13 | $0.1400 | 0.0% |
| 2024-06-14 | $0.1400 | +7.7% |
| 2024-03-14 | $0.1300 | 0.0% |
| 2023-12-14 | $0.1300 | 0.0% |
| 2023-09-14 | $0.1300 | 0.0% |
| 2023-06-14 | $0.1300 | 0.0% |
Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XTL or IYZ, the fund manager is mechanically forced to buy or sell IRDM shares regardless of IRDM's individual fundamentals. We estimate $246M of passive capital is structurally linked to IRDM through 8 tracked ETFs. Passive flows have a limited but growing influence on IRDM's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in IRDM to visualize passive redemption contagion across ETFs and collateral stocks.
If IRDM (IRDM) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Cisco Systems Inc (CSCO) as the most exposed collateral stock, sharing 1 ETFs with IRDM. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 15 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
IRDM Ownership Dynamics
Passive funds hold 1 in every 13 IRDM shares, reducing daily market volatility.
IRDM (IRDM) exerts measurable gravity on the passive index market, currently representing 5.1% of the XTL (XTL) and 4.9% of the IYZ (IYZ). Across 15 tracked ETFs, approximately 8M shares (7.8% of float) are held by passive funds and rarely trade on the open market. As passive ownership grows, index inclusion changes may increasingly drive price discovery.
ETFs with Highest IRDM Exposure
Float lock-up computed from 15 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
IRDM Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for IRDM over the past year sits near $18.19 (26% of 252-day volume). The current price of $49.60 trades 172.7% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (26% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
IRDM Capital Efficiency
How efficiently does IRDM convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
IRDM converts 68% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 0.9% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-08 | 60 | $40.19 | $2,411.4 |
| 2026-05-06 | 1,243 | $39.23 | $48,762.89 |
| 2026-04-30 | 3,570 | $36.39 | $129,912.3 |
| 2026-04-22 | 1 | $42.93 | $42.93 |
| 2026-04-20 | 4,602 | $41.85 | $192,593.7 |
| 2026-04-09 | 4,784 | $34.62 | $165,622.08 |
| 2026-04-07 | 37 | $32.79 | $1,213.23 |
| 2026-04-06 | 2,656 | $32.86 | $87,276.16 |
| 2026-04-02 | 5 | $28.52 | $142.6 |
| 2026-03-31 | 97 | $26.81 | $2,600.57 |
| 2026-03-30 | 322 | $27.96 | $9,003.12 |
| 2026-03-23 | 7,461 | $25.40 | $189,509.4 |
| 2026-03-18 | 9,952 | $26.24 | $261,140.48 |
| 2026-03-10 | 879 | $24.24 | $21,306.96 |
| 2026-03-03 | 85 | $24.77 | $2,105.45 |
| 2026-02-23 | 4,275 | $22.92 | $97,983 |
| 2026-02-18 | 354 | $23.53 | $8,329.62 |
| 2026-02-17 | 710 | $23.17 | $16,450.7 |
| 2026-02-13 | 16,623 | $22.39 | $372,188.97 |
| 2026-02-12 | 2,228 | $18.46 | $41,128.88 |
| 2025-12-30 | 20 | $17.15 | $343 |
| 2025-12-29 | 57 | $17.21 | $980.97 |
| 2025-12-22 | 4,067 | $17.04 | $69,301.68 |
| 2025-12-18 | 131 | $16.59 | $2,173.29 |
| 2025-12-17 | 274 | $16.87 | $4,622.38 |
| 2025-12-16 | 26 | $17.60 | $457.6 |
| 2025-11-26 | 806 | $16.45 | $13,258.7 |
| 2025-11-19 | 49 | $16.15 | $791.35 |
| 2025-11-17 | 73 | $16.54 | $1,207.42 |
| 2025-11-14 | 498 | $16.69 | $8,311.62 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| CGNX | 0.397 | 0.521 | Moderate |
| GSAT | 0.380 | 0.550 | Moderate |
| TXT | 0.375 | 0.278 | Moderate |
| VSAT | 0.362 | 0.497 | Moderate |
| FSLY | 0.345 | 0.436 | Moderate |
| RS | 0.342 | 0.099 | Moderate |
| ASTS | 0.311 | 0.325 | Moderate |
| WAB | 0.310 | 0.209 | Moderate |
| EQIX | 0.306 | 0.464 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare IRDM to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.